MEDFORD, MA AND COLUMBIA, MD, August 20, 2019 - Advanced BioNutrition (ABN) and GreenLight Biosciences (GreenLight) announce today a collaboration to develop high stability RNA products for specific agriculture applications. The companies will collaborate to increase the stability and performance of RNA technology from GreenLight in order to meet the increasing demand by growers, consumers and the food industry for more sustainable pest control solutions.
June 27, 2019 (Columbia, Maryland) – Advanced BioNutrition Corp. (ABN), a leading provider of advanced stabilization and delivery solutions across the health and nutrition, agriculture, and biopharma industries, announced today that it is collaborating with Myron M. Levine, MD, DTPH, Simon and Bessie Grollman Distinguished Professor of Medicine at the University of Maryland School of Medicine’s (UMSOM) Center for Vaccine Development and Global Health (CVD), to test a new formulation of a live oral Salmonella Paratyphi A vaccine to prevent paratyphoid fever.
Advanced BioNutrition will be attending the SupplySide West Expo this November 8th & 9th at the Mandalay Bay Resort and Casino in LasVegas Nevada. ABN’s Frank DeGennaro (CEO), Bruce Artman (Director Business Development) and Brian Carpenter (Project Manager) will be in attendance to discuss bioactive stabilization and delivery opportunities with current and new collaborators. In addition, Frank DeGennaro will be speaking at the Nutrition Capital Network Investor Conference on November 7th. SupplySide West brings together over 1,300 exhibitors and 16,000 participants from the dietary supplement, beverage, functional food, personal care and sports nutrition industry. If you would like to schedule a discussion with the ABN team please contact Bruce Artman at email@example.com.
Columbia, MD - September 12, 2018 (Business Wire)-- Dr. Mark Thompson has been named Vice President of Research and Development at Advanced BioNutrition Corp. (ABN). He succeeds Dr. Robert Ackerson who recently retired.
Mark joined ABN in June 2018. He brings over 35 years of experience from DuPont in a variety of R&D leadership roles, including 24 years in the Crop Protection business in R&D and Operations and several years in DuPont's LYCRA Spandex business leading New Products R&D. In his last position at DuPont, Mark served as Research Director in DuPont's Central Research Division where he collaborated with all businesses overseeing diverse, innovation projects in materials science, renewably-sourced polymers, industrial bioprocesses, and novel delivery systems for Production Agriculture.
"We are thrilled to have Dr. Thompson join ABN," said Mr. Frank DeGennaro, CEO. " Mark’s highly successful track record of leading R&D organizations to rapidly develop and commercialize new innovation will certainly enhance our customers’ ability to create value with ABN technologies."
As part of the company’s strategy to focus on Human Health and Nutrition, Agriculture and Biopharma, ABN recently sold its business and assets in the Animal Health and Nutrition field. ABN is now pioneering new verticals by expanding their core technologies available from over 40 patent families. ABN's research team of biologists, chemists, food scientists, agronomists, and engineers, specializes in innovation related to stabilization and delivery of a broad range of bioactives including probiotics, yeast, vaccines, enzymes, peptides, bacteriophage, vitamins, ag biologicals, and seed inoculants.
Columbia, MD - Friday 06 July 2018 – Tom Fort and Jim Reap will be attending the Crops and Chemicals Conference in Raleigh, NC July 24-25, where they will be presenting a poster entitled “Advanced BioNutrition's Dry Powder Formulation Approach to Stabilize Biologicals”. The presentation outlines key stability results and highlights ABN's proprietary encapsulation technologies that offer superior performance with respect to stabilizing bioactive microbes for agriculture utilizing ingredients generally recognized as safe (GRAS) by regulatory authorities.
ABN's Protect&Deliver™ technology is a novel stabilization platform, which considerably improves the stability of biological microbials for agriculture including on shelf and on seed stability.
Columbia, MD - Monday 04 June 2018 – Brian Carpenter will be attending the Probiota Americas 2018 Conference June 5th - 7th, in Miami Florida, where he will be presenting a poster entitled “Preservation of Probiotic Bacteria in Various Food Products” during the networking reception 6:30PM on June 5th. Brian’s presentation highlights the demonstrated performance of ABN’s probiotic stabilization technology in foods containing high moisture concentrations.
ABN's Protect&Deliver™ technology is a novel stabilization platform, which considerably improves the stability of probiotic bacteria incorporated into an array of food applications, some of which include infant formula, nutritional supplements, powdered drink mixes, musli bars, and breakfast cereals.
ABN technology has been used to stabilize and protect a couple of commonly utilized materials that are used to combat food borne illnesses. As antibiotic resistance becomes an increasingly important issue, new approaches to preventing bacterial food contamination are being explored and developed. Protection, stabilization and delivery of agents used to help ensure food safety will become more important in the future. ABN technology may well help in developing innovative and novel approaches to addressing food safety concerns.
The ABN team works closely with clients to fully comprehend the specific product requirements that will be embodied in subsequent stabilization and protection of sensitive bioactives. This collaboration begins during the proof of concept stage of a project and extends through development, licensing and technology transfer activities. Our interdisciplinary team of biologists, chemists, food scientists, agronomists, and engineers, creates innovative solutions utilizing their broad expertise and deep technology platform supported by more than 40 owned and exclusively licensed patents. Through extensive experience, this collaborative approach has proven highly effective and commercially successful.